|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 13
Zeitschriftenartikel
Mekota, Anna -Maria; Gillespie, Stephen H.; Hoelscher, Michael; Diacon, Andreas H.; Dawson, Rodney; Churchyard, Gavin; Sanne, Ian; Minja, Lilian; Kibiki, Gibson; Maboko, Leonard; Lakhi, Shabir; Joloba, Moses; Alabi, Abraham; Kirenga, Bruce; McHugh, Timothy D.; Grobusch, Martin P. und Boeree, Martin J.
(2022):
Building sustainable clinical trial sites in Sub-Saharan Africa through networking, infrastructure improvement, training and conducting clinical studies: The PanACEA approach.
In: Acta Tropica, Bd. 238, 106776
McHugh, Martin P.; Parcell, Benjamin J.; Pettigrew, Kerry A.; Toner, Geoff; Khatamzas, Elham; El Sakka, Noha; Karcher, Anne Marie; Walker, Joanna; Weir, Robert; Meunier, Daniele; Hopkins, Katie L.; Woodford, Neil; Templeton, Kate E.; Gillespie, Stephen H. und Holden, Matthew T. G.
(2022):
Presence of optrA- mediated linezolid resistance in multiple lineages and plasmids of Enterococcus faecalis revealed by long read sequencing.
In: Microbiology, Bd. 168, Nr. 2, 1137
Heyckendorf, Jan; Georghiou, Sophia B.; Frahm, Nicole; Heinrich, Norbert; Kontsevaya, Irina; Reimann, Maja; Holtzman, David; Imperial, Marjorie; Cirillo, Daniela M.; Gillespie, Stephen H. und Ruhwald, Morten
(2022):
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies.
In: Clinical Microbiology Reviews, Bd. 35, Nr. 3, e00227-21
Azam, Khalide; Khosa, Celso; Viegas, Sofia; Massango, Isabel; Bhatt, Nilesh; Jani, Ilesh; Heinrich, Norbert; Hoelscher, Michael; Gillespie, Stephen H.; Rachow, Andrea und Sabiiti, Wilber
(2022):
Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy.
In: Frontiers in Immunology, Bd. 13, 1005692
Brake, Lindsey H. M. te; de Jager, Veronique; Narunsky, Kim; Vanker, Naadira; Svensson, Elin M.; Phillips, Patrick P. J.; Gillespie, Stephen H.; Heinrich, Norbert; Hoelscher, Michael; Dawson, Rodney; Diacon, Andreas H.; Aamoutse, Rob E. und Boeree, Martin J.
(2021):
Increased bactericidal activity but dose-limiting intolerability at 50 mg.kg(-1) rifampicin.
In: European Respiratory Journal, Bd. 58, Nr. 1, 2000955
Sabiiti, Wilber; Azam, Khalide; Farmer, Eoghan Charles William; Kuchaka, Davis; Mtafya, Bariki; Bowness, Ruth; Oravcova, Katarina; Honeyborne, Isobella; Evangelopoulos, Dimitrios; McHugh, Timothy Daniel; Khosa, Celso; Rachow, Andrea; Heinrich, Norbert; Kampira, Elizabeth; Davies, Geraint; Bhatt, Nilesh; Ntinginya, Elias N.; Viegas, Sofia; Jani, Ilesh; Kamdolozi, Mercy; Mdolo, Aaron; Khonga, Margaret; Boeree, Martin J.; Phillips, Patrick P. J.; Sloan, Derek; Hoelscher, Michael; Kibiki, Gibson und Gillespie, Stephen H.
(2020):
Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay.
In: Thorax, Bd. 75, Nr. 7: S. 606-608
[PDF, 703kB]
Sabiiti, Wilber; Azam, Khalide; Esmeraldo, Ezembro; Bhatt, Nilesh; Rachow, Andrea und Gillespie, Stephen H.
(2019):
Heat Inactivation Renders Sputum Safe and Preserves Mycobacterium tuberculosis RNA for Downstream Molecular Tests.
In: Journal of Clinical Microbiology, Bd. 57, Nr. 4, UNSP e01778-18
Rachow, Andrea; Saathoff, Elmar; Mtafya, Bariki; Mapamba, Daniel; Mangu, Chacha; Rojas-Ponce, Gabriel; Ntinginya, Nyanda E.; Böree, Martin; Heinrich, Norbert; Gillespie, Stephen H. und Hölscher, Michael
(2018):
The impact of repeated NALC/NaOH- decontamination on the performance of Xpert MTB/RIF assay.
In: Tuberculosis, Bd. 110: S. 56-58
Svensson, Elin M.; Svensson, Robin J.; te Brake, Lindsey H. M.; Böree, Martin J.; Heinrich, Norbert; Konsten, Sarah; Churchyard, Gavin; Dawson, Rodney; Diacon, Andreas H.; Kibiki, Gibson S.; Minja, Lilian T.; Ntingiya, Nyanda E.; Saone, Ian; Gillespie, Stephen H.; Hölscher, Michael; Phillips, Patrick P. J.; Simonsson, Ulrika S. H. und Aarnoutse, Rob
(2018):
The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.
In: Clinical Infectious Diseases, Bd. 67, Nr. 1: S. 34-41
Ahmed, Mohamed I. M.; Ntinginya, Nyanda E.; Kibiki, Gibson; Mtafya, Bariki A.; Semvua, Hadija; Mpagama, Stellah; Mtabho, Charles; Saathoff, Elmar; Held, Kathrin; Loose, Rebecca; Kroidl, Inge; Chachage, Mkunde; Both, Ulrich von; Haule, Antelmo; Mekota, Anna-Maria; Böree, Martin J.; Gillespie, Stephen H.; Hoelscher, Michael; Heinrich, Norbert und Geldmacher, Christof
(2018):
Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy.
In: Frontiers in Immunology, Bd. 9, 2247
[PDF, 4MB]
Boeree, Martin J.; Heinrich, Norbert; Aarnoutse, Rob; Diacon, Andreas H.; Dawson, Rodney; Rehal, Sunita; Kibiki, Gibson S.; Churchyard, Gavin; Sanne, Ian; Ntinginya, Nyanda E.; Minja, Lilian T.; Hunt, Robert D.; Charalambous, Salome; Hanekom, Madeleine; Semvua, Hadija H.; Mpagama, Stellah G.; Manyama, Christina; Mtafya, Bariki; Reither, Klaus; Wallis, Robert S.; Venter, Amour; Narunsky, Kim; Mekota, Anka; Henne, Sonja; Colbers, Angela; Plemper van Balen, Georgette; Gillespie, Stephen H.; Phillips, Patrick P. J. und Hölscher, Michael
(2017):
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
In: Lancet infectious Diseases, Bd. 17, Nr. 1: S. 39-49
Phillips, Patrick P. J.; Dooley, Kelly E.; Gillespie, Stephen H.; Heinrich, Norbert; Stout, Jason E.; Nahid, Payam; Diacon, Andreas H.; Aarnoutse, Rob E.; Kibiki, Gibson S.; Boeree, Martin J. und Hoelscher, Michael
(2016):
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP).
In: BMC Medicine
14:51
[PDF, 2MB]
Boeree, Martin J.; Gillespie, Stephen H. und Hölscher, Michael
(2016):
Therapy for Tuberculous Meningitis.
In: New England Journal of Medicine, Bd. 374, Nr. 22: S. 2187-2188